Journal article
Prescribing in pregnancy for women with diabetes: Use of potential teratogenic drugs and contraception
SI Makda, MJ Davies, E Wilmot, J Bankart, T Yates, EM Varghese, H Fisher, A Anwar, K Khunti
Diabetic Medicine | WILEY | Published : 2013
DOI: 10.1111/dme.12051
Abstract
Aims To describe contraception use and the prescription of drugs that are either not recommended in pregnancy or are potentially teratogenic by diabetes type in women of child-bearing age. Methods Retrospective, cross-sectional chart review undertaken in 22 general practices in Warwickshire, UK. Demographic, anthropometric, medical history, medication and contraception data were extracted from women aged 14 to 49 years with pre-existing diabetes. Independent sample t-test, Mann–Whitney test and Χ2-test were used to test for univariable associations and multiple logistic regression was used to adjust for confounders. Results Four hundred and seventy eligible women were identified; the majorit..
View full abstractGrants
Awarded by Health Research
Funding Acknowledgements
MJD has received funds for research, honoraria for speaking at meetings and has served on Advisory Boards for Lilly, Sanofi Aventis, MSD, Novo Nordisk, BMS, BI and Roche. KK has received funds for research, honoraria for speaking at meetings and/or served on Advisory Boards for Astra Zeneca, Lilly, Novartis, Pfizer, Servier, Sanofi Aventis, MSD and Novo Nordisk.We thank all the general practices who have contributed to this study. MJD and KK are grateful for support from the National Institute for Health Research Collaboration in Applied Health Research and Care for Leicestershire, Northamptonshire and Rutland (NIHR LNR CLAHRC). AA is grateful for the support from the Association of British Clinical Diabetologists (ABCD).